Home › Teva Bolsters Injectable Portfolio With Launch Of Generic Lovenox And Generic Zyvox In The United States
 

Keywords :   


Teva Bolsters Injectable Portfolio With Launch Of Generic Lovenox And Generic Zyvox In The United States

2015-02-23 05:09:10| chemicalonline News Articles

Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company, recently announced the launch of the generic equivalent of Lovenox (enoxaparin sodium injection) in seven dosage strengths in the United States

Tags: the united states portfolio

Category:Chemicals

Latest from this category

All news
25.11Global Market Insights: Auto Refinish Coating Market $17.79 Billion by 2032
23.11Weekly Recap: PPG, John Morikis, Sika Top This Weeks Stories
22.11Andrea Wagner Watts to Deliver Keynote Address at ACAs 2025 CoatingsTech Conference
22.11Hempels Infinity Silicone Hull Paint Recharger Launched for Yachts
22.11The Lehigh 56th Annual Short Course Website is Open
21.11allnex Announces Strategic Investment in East St. Louis Site
21.11Syensqo Expands Polymer Production Capacity
21.11¦nie¿ka Publishes Results for Three Quarters of 2024
Chemicals »
25.111/18CTS-V
25.11
25.111
25.11ARS 10+ EHERO 3
25.11 16MGL HG
25.11
25.11GREENMAX 4470 22600Ace4
25.11
More »